Description
CYTOCLAV DT 228.5MG is a potent dispersible tablet antibiotic, specifically formulated for ease of administration, particularly in children. Each tablet contains a precise combination of Amoxicillin (200mg) and Clavulanate Potassium (28.5mg). Amoxicillin, a broad-spectrum penicillin antibiotic, works by inhibiting bacterial cell wall formation, leading to bacterial death. Clavulanate Potassium is a crucial beta-lactamase inhibitor that protects amoxicillin from enzymes produced by resistant bacteria, thereby extending its antibacterial spectrum and ensuring its efficacy against a wider range of challenging infections.
This combination makes CYTOCLAV DT 228.5MG highly effective for treating various bacterial infections, including respiratory tract infections (such as otitis media, sinusitis, bronchitis, pneumonia), urinary tract infections, and skin and soft tissue infections. Its dispersible form allows it to be dissolved in water, providing a convenient and palatable option for patients who struggle with swallowing traditional tablets. As a prescription-only medication, it is vital to complete the full course as directed by a healthcare professional to achieve optimal results and prevent antibiotic resistance.
